
Luca Bollo
@bollo_luca
Followers
359
Following
426
Media
25
Statuses
121
Neurologist | PhD student | Centre d’Esclerosi Múltiple de Catalunya (CEMCAT) @cemcat_em | Vall d’Hebron University Hospital | @UABBarcelona | 📍Barcelona
Barcellona, Spagna
Joined October 2021
Proud to announce our study on neurodegeneration in the visual pathway of MOGAD patients in @GreenJournal. The result of great collaboration between @cemcat (@AvidalJordana, @XMontalban) and @NeuroRX_hebron (DeborahPareto, @alexrovirarayos).
neurology.org
Background and ObjectivesWe aimed to assess the presence of retinal neurodegeneration independent of optic neuritis (ON) in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and...
4
32
81
RT @ECTRIMS: 🚀 Kudos to the faculty & participants for making the 2025 Summer School a success! Over the last 3 days, attendees truly honed….
0
3
0
RT @ECTRIMS: 🔔 Join our upcoming webinar! Understand the key suggested improvements to the #McDonaldCriteria for #MS diagnosis. Hear from e….
0
7
0
RT @XMontalban: Congrats @anazabalza for this very informative review on : Multiple sclerosis and COVID-19: interactions and unresolved iss….
0
6
0
RT @andreuvilaseca7: MS lacks a specific diagnostic biomarker, so considering alternative diagnoses is crucial,especially in high-risk pati….
0
16
0
RT @cobo_calvo: The impact of ageingt on long-term outcomes in MS.
neurology.org
Background and ObjectivesEmerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is...
0
12
0
RT @Villacieros_J: Interested in the controversial role of the complement system in #MOGAD? We are happy to share our study where we measur….
neurology.org
Background and ObjectivesThe role of the complement system in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is not completely understood, and studies exploring its potential...
0
14
0
How evolving RRMS diagnostic criteria, including optic nerve lesions and less stringent DIT requirements, can be feasibly applied to PPMS without compromising diagnostic accuracy. New paper by @DrWBRO of @UCLIoN in collaboration with @MAGNIMS.
onlinelibrary.wiley.com
Objective The 2017 McDonald criteria continued the separation of diagnostic criteria for relapsing–remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS) for historical, rather than...
0
5
14
RT @cemcat_em: 📣 Próxima sesión de Casos Clínicos en EM Pediátrica: NMOSD en niños y adolescentes: identificadores clave para su diagnósti….
0
1
0
RT @J_SastreGarriga: It is a tremendous honor, something I could not expect at all back in 1999 when I attended my first @ECTRIMS meeting.….
0
10
0
RT @Neus_Mongay: My biggest congratulations to .Dr. Jaume Sastre-Garriga to have been elected as one of the new committee members of the EC….
0
9
0
Excited to have just presented at #ECTRIMS2024 our work showing that thalamic atrophy at baseline predicts PIRA in early-MS. These patients show microstructural damage in the thalamus near the ventricle, supporting CSF-mediated damage hypothesis. @cemcat_em @AVidalJordana
0
9
43
Retinal hyperreflective foci (HRF) as a biomarker of cerebral microglial activation: all hype or real hope? . Our data in primary progressive MS and relapsing MS will be presented in the poster session this afternoon (P914) at #ECTRIMS. @AVidalJordana @cemcat_em
0
1
14
The presentation of the 2024 revised diagnostic criteria for multiple sclerosis by Xavier Montalban is currently underway in Copenhagen at #ECTRIMS2024, in a packed plenary session. A key step toward improving early diagnosis and care. @ECTRIMS @XMontalban @cemcat_em
0
15
56
RT @J_SastreGarriga: Happy to share with you our recent @MAGNIMS article on the Value of Optic Nerve MRI in Multiple Sclerosis Clinical Man….
0
21
0
RT @ECTRIMS: Join Prof. Xavier Montalban (@XMontalban) as he shares insights into the McDonald Criteria ahead of the #ECTRIMS2024 session,….
0
19
0
RT @CarmenTur1: Are you a passionate researcher ready to dive into the world of multi-omic multiple sclerosis data and harness the power of….
0
10
0
It was great to be a part of MEDEN in Berlin organized by @ChariteBerlin with my colleagues from @cemcat_em. Fantastic opportunity to discuss projects with other young researchers from all over Europe in an amazing setting. @Villacieros_J @cobo_calvo @GeoArrambide
0
2
13
RT @MSJ_Research: Among 258 people with #MultipleSclerosis treated with monoclonal antibodies (natalizumab, ocrelizumab, ofatumumab, rituxi….
0
12
0
RT @GreenJournal: Announcing Neurology's new Assistant Editors, Marcello Moccia, MD, PhD, and Angela Vidal-Jordana, MD, PhD. Drs. Moccia &….
0
8
0